Bevacizumab (anti-VEGF) 216974-75-3

價(jià)格	詢價(jià)
包裝	100mg	500mg	1000mg

最小起訂量	100mg
發(fā)貨地	上海
更新日期	2026-07-28

產(chǎn)品詳情

中文名稱:貝伐單抗	英文名稱:Bevacizumab (anti-VEGF)
CAS:216974-75-3	品牌: Topwell
產(chǎn)地: 上海市	保存條件: -30 ℃
純度規(guī)格: 98% SEC-HPLC	產(chǎn)品類別: 生物類似抗體
靶點(diǎn): VEGF-A	生物作用: Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions.
應(yīng)用: Bevacizumab is vascular endothelial growth factor directed antibody.

Product Name: Bevacizumab (anti-VEGF) | RhuMab VEGF

CAS:216974-75-3

MW: 149 kDa

Storage condition:Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles.
Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.
For research use only

關(guān)鍵字： Bevacizumab;216974-75-3;

公司簡介

Shanghai Topwell Pharma Co., Ltd. is specialized in research, development, custom manufacturing and sales of APIs, Pharmaceutical Excipients, Health & Nutritional Ingredients, Polypeptides and Antibodies, etc.. Topwell has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories. Topwell aims to become a global leader in pharmaceutical & chemical industry. 上海拓普韋爾生物醫(yī)藥科技有限公司專注于小分子藥物發(fā)現(xiàn)領(lǐng)域的分子砌塊和工具化合物的研究開發(fā)，為全球醫(yī)藥企業(yè)和科研機(jī)構(gòu)提供從藥物發(fā)現(xiàn)到原料藥和醫(yī)藥中間體的規(guī)模化生產(chǎn)的相關(guān)產(chǎn)品和技術(shù)服務(wù)。

成立日期	2020-07-17 （7年）	注冊資本	300萬人民幣
員工人數(shù)	10-50人	年?duì)I業(yè)額	￥ 500萬-1000萬
主營行業(yè)	標(biāo)準(zhǔn)品和對(duì)照品,醫(yī)藥中間體,癌癥研究,生物活性小分子,診斷試劑	經(jīng)營模式	工廠,試劑,定制,服務(wù)

上海拓普韋爾生物醫(yī)藥科技有限公司

普通會(huì)員

公司成立：7年
注冊資本：300萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：Health & Nutritional Ingredients, Polypeptides and Antibodies
公司地址：Building 3, No.1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone 201413 P.R. China

進(jìn)入店鋪

詢盤

店內(nèi)推薦

Trastuzumab (anti-HER2) 曲妥珠單抗 180288-69-1

詢價(jià)

Ranibizumab 347396-82-1

詢價(jià)

Cetuximab 205923-56-4

詢價(jià)